Follow The Filings

ORMP Oramed Pharmaceuticals

Oramed Pharmaceuticals earnings company data as of 4:48 AM ET 10/4

Scheduled

1 period · newest first · EPS & Rev stacked · nothing reported yet

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS 0.43 — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR · 12 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.07
10-Q QUARTERLY REPORT
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 5.03,8.01,9.01
10-Q QUARTERLY REPORT
8-K 1.01,2.01
10-K ANNUAL REPORT
8-K 1.01,9.01
8-K 1.01,8.01,9.01
8-K 8.01,9.01
8-K 8.01
8-K 5.02

Insider forms

Form 3 / 4 / 5 from EDGAR · 2 rows shown

Filed Form Detail Links
4 Period Oct 1, 2026 · 2 forms
4 Period Sep 24, 2026 · 3 forms

20 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice